Hollsteen
← Verisk

Cash and equivalents

Balance – as of period end · $M

QuartersFiscal years

$MCash and equivalents · Q1 2016: $132M · 10-Q 0001442145-17-000025 filed May 2, 2017Cash and equivalents · Q2 2016: $196M · 10-Q 0001442145-17-000035 filed Aug 1, 2017Cash and equivalents · Q3 2016: $165M · 10-Q 0001442145-17-000045 filed Oct 31, 2017Cash and equivalents · Q4 2016: $135M · 10-K 0001442145-17-000010 filed Feb 21, 2017Cash and equivalents · Q1 2017: $155M · 10-Q 0001442145-17-000025 filed May 2, 2017Cash and equivalents · Q2 2017: $141M · 10-Q 0001442145-17-000035 filed Aug 1, 2017Cash and equivalents · Q3 2017: $142M · 10-Q 0001442145-17-000045 filed Oct 31, 2017Cash and equivalents · Q4 2017: $142M · 10-K 0001442145-18-000008 filed Feb 20, 2018Cash and equivalents · Q1 2018: $150M · 10-Q 0001442145-18-000024 filed May 1, 2018Cash and equivalents · Q2 2018: $132M · 10-Q 0001442145-18-000036 filed Jul 31, 2018Cash and equivalents · Q3 2018: $148M · 10-Q 0001442145-18-000055 filed Oct 30, 2018Cash and equivalents · Q4 2018: $140M · 10-K 0001442145-19-000012 filed Feb 19, 2019Cash and equivalents · Q1 2019: $180M · 10-Q 0001442145-19-000022 filed Apr 30, 2019Cash and equivalents · Q2 2019: $153M · 10-Q 0001442145-19-000036 filed Jul 30, 2019Cash and equivalents · Q3 2019: $312M · 10-Q 0001442145-19-000048 filed Oct 30, 2019Cash and equivalents · Q4 2019: $185M · 10-K 0001442145-20-000012 filed Feb 18, 2020Cash and equivalents · Q1 2020: $204M · 10-Q 0001442145-20-000022 filed May 5, 2020Cash and equivalents · Q2 2020: $309M · 10-Q 0001437749-20-016475 filed Aug 4, 2020Cash and equivalents · Q3 2020: $222M · 10-Q 0001437749-20-022527 filed Nov 4, 2020Cash and equivalents · Q4 2020: $219M · 10-K 0001437749-21-003789 filed Feb 23, 2021Cash and equivalents · Q1 2021: $391M · 10-Q 0001437749-21-010755 filed May 4, 2021Cash and equivalents · Q2 2021: $276M · 10-Q 0001437749-21-018343 filed Aug 3, 2021Cash and equivalents · Q3 2021: $302M · 10-Q 0001437749-21-024931 filed Nov 2, 2021Cash and equivalents · Q4 2021: $112M · 10-K 0001437749-23-004945 filed Feb 28, 2023Cash and equivalents · Q1 2022: $398M · 10-Q 0001437749-22-010671 filed May 3, 2022Cash and equivalents · Q2 2022: $481M · 10-Q 0001437749-22-018437 filed Aug 2, 2022Cash and equivalents · Q3 2022: $277M · 10-Q 0001437749-22-025374 filed Nov 1, 2022Cash and equivalents · Q4 2022: $112M · 10-K 0001437749-23-004945 filed Feb 28, 2023Cash and equivalents · Q1 2023: $232M · 10-Q 0001437749-23-012195 filed May 3, 2023Cash and equivalents · Q2 2023: $309M · 10-Q 0001437749-23-021529 filed Aug 2, 2023Cash and equivalents · Q3 2023: $417M · 10-Q 0001437749-23-029653 filed Nov 1, 2023Cash and equivalents · Q4 2023: $303M · 10-K 0001437749-24-004939 filed Feb 21, 2024Cash and equivalents · Q1 2024: $352M · 10-Q 0001437749-24-014064 filed May 1, 2024Cash and equivalents · Q2 2024: $632M · 10-Q 0001437749-24-023985 filed Jul 31, 2024Cash and equivalents · Q3 2024: $458M · 10-Q 0001437749-24-032536 filed Oct 30, 2024Cash and equivalents · Q4 2024: $291M · 10-K 0001437749-25-005160 filed Feb 26, 2025Cash and equivalents · Q1 2025: $1.1B · 10-Q 0001437749-25-014907 filed May 7, 2025Cash and equivalents · Q2 2025: $629M · 10-Q 0001437749-25-023862 filed Jul 30, 2025Cash and equivalents · Q3 2025: $2.1B · 10-Q 0001437749-25-032073 filed Oct 29, 2025Cash and equivalents · Q4 2025: $2.2B · 10-K 0001437749-26-004452 filed Feb 18, 2026Cash and equivalents · Q1 2026: $524M · 10-Q 0001437749-26-013729 filed Apr 29, 20263095241322,178Q1 2016Q1 2026Q2 2020
$MCash and equivalents · Q2 2019: $153M · 10-Q 0001442145-19-000036 filed Jul 30, 2019Cash and equivalents · Q3 2019: $312M · 10-Q 0001442145-19-000048 filed Oct 30, 2019Cash and equivalents · Q4 2019: $185M · 10-K 0001442145-20-000012 filed Feb 18, 2020Cash and equivalents · Q1 2020: $204M · 10-Q 0001442145-20-000022 filed May 5, 2020Cash and equivalents · Q2 2020: $309M · 10-Q 0001437749-20-016475 filed Aug 4, 2020Cash and equivalents · Q3 2020: $222M · 10-Q 0001437749-20-022527 filed Nov 4, 2020Cash and equivalents · Q4 2020: $219M · 10-K 0001437749-21-003789 filed Feb 23, 2021Cash and equivalents · Q1 2021: $391M · 10-Q 0001437749-21-010755 filed May 4, 2021309391153Q2 2019Q1 2021Q2 2020
Q2 2020
309$M
All values (41)
PeriodValue ($M)Status
Q1 2026524reported
Q4 20252,178reported
Q3 20252,108reported
Q2 2025629reported
Q1 20251,112reported
Q4 2024291reported
Q3 2024458reported
Q2 2024632reported
Q1 2024352reported
Q4 2023303reported
Q3 2023417reported
Q2 2023309reported
Q1 2023232reported
Q4 2022112reported
Q3 2022277reported
Q2 2022481reported
Q1 2022398reported
Q4 2021112reported
Q3 2021302reported
Q2 2021276reported
Q1 2021391reported
Q4 2020219reported
Q3 2020222reported
Q2 2020309reported
Q1 2020204reported
Q4 2019185reported
Q3 2019312reported
Q2 2019153reported
Q1 2019180reported
Q4 2018140reported
Q3 2018148reported
Q2 2018132reported
Q1 2018150reported
Q4 2017142reported
Q3 2017142reported
Q2 2017141reported
Q1 2017155reported
Q4 2016135reported
Q3 2016165reported
Q2 2016196reported
Q1 2016132reported

CSV with all sources · Technical ID: cash

More metrics for Verisk

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$309M
Period
Q2 2020, ended Jun 30, 2020 · as of Jun 30, 2020 (balance as of date, not a sum)
Source
10-Q, filed Aug 4, 2020 · 0001437749-20-016475
Location
us-gaap:CashAndCashEquivalentsAtCarryingValue
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$309MAug 4, 202010-Q 0001437749-20-016475reported · confidence 1. · current